| Product Code: ETC6767776 | Publication Date: Sep 2024 | Updated Date: Nov 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Vasudha | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
In 2024, Colombia continued to import large molecule drug substances from top countries including South Korea, China, Germany, United Kingdom, and the United States. Despite a negative compound annual growth rate (CAGR) of -6.0% from 2020 to 2024, the market experienced a significant decline in growth rate of -48.46% from 2023 to 2024. The High Herfindahl-Hirschman Index (HHI) suggests a sustained high concentration of imports among these key exporting nations, indicating a competitive market environment with dominant players in the industry.

1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Colombia Large Molecule Drug Substance CDMO Market Overview |
3.1 Colombia Country Macro Economic Indicators |
3.2 Colombia Large Molecule Drug Substance CDMO Market Revenues & Volume, 2021 & 2031F |
3.3 Colombia Large Molecule Drug Substance CDMO Market - Industry Life Cycle |
3.4 Colombia Large Molecule Drug Substance CDMO Market - Porter's Five Forces |
3.5 Colombia Large Molecule Drug Substance CDMO Market Revenues & Volume Share, By Service, 2021 & 2031F |
3.6 Colombia Large Molecule Drug Substance CDMO Market Revenues & Volume Share, By Source, 2021 & 2031F |
3.7 Colombia Large Molecule Drug Substance CDMO Market Revenues & Volume Share, By End-user, 2021 & 2031F |
4 Colombia Large Molecule Drug Substance CDMO Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing demand for complex biologics and large molecule drugs in Colombia |
4.2.2 Growing adoption of contract development and manufacturing organizations (CDMOs) for large molecule drug substance production |
4.2.3 Favorable government regulations and policies supporting the pharmaceutical industry in Colombia |
4.3 Market Restraints |
4.3.1 Limited expertise and infrastructure for large molecule drug substance manufacturing in the country |
4.3.2 High initial investment required for setting up large molecule drug substance production facilities in Colombia |
5 Colombia Large Molecule Drug Substance CDMO Market Trends |
6 Colombia Large Molecule Drug Substance CDMO Market, By Types |
6.1 Colombia Large Molecule Drug Substance CDMO Market, By Service |
6.1.1 Overview and Analysis |
6.1.2 Colombia Large Molecule Drug Substance CDMO Market Revenues & Volume, By Service, 2021- 2031F |
6.1.3 Colombia Large Molecule Drug Substance CDMO Market Revenues & Volume, By Contract Manufacturing, 2021- 2031F |
6.1.4 Colombia Large Molecule Drug Substance CDMO Market Revenues & Volume, By Clinical, 2021- 2031F |
6.1.5 Colombia Large Molecule Drug Substance CDMO Market Revenues & Volume, By Commercial, 2021- 2031F |
6.1.6 Colombia Large Molecule Drug Substance CDMO Market Revenues & Volume, By Contract Development, 2021- 2031F |
6.1.7 Colombia Large Molecule Drug Substance CDMO Market Revenues & Volume, By Cell Line Development, 2021- 2031F |
6.1.8 Colombia Large Molecule Drug Substance CDMO Market Revenues & Volume, By Process Development, 2021- 2031F |
6.2 Colombia Large Molecule Drug Substance CDMO Market, By Source |
6.2.1 Overview and Analysis |
6.2.2 Colombia Large Molecule Drug Substance CDMO Market Revenues & Volume, By Mammalian, 2021- 2031F |
6.2.3 Colombia Large Molecule Drug Substance CDMO Market Revenues & Volume, By Microbial, 2021- 2031F |
6.2.4 Colombia Large Molecule Drug Substance CDMO Market Revenues & Volume, By Others, 2021- 2031F |
6.3 Colombia Large Molecule Drug Substance CDMO Market, By End-user |
6.3.1 Overview and Analysis |
6.3.2 Colombia Large Molecule Drug Substance CDMO Market Revenues & Volume, By Biotech Companies, 2021- 2031F |
6.3.3 Colombia Large Molecule Drug Substance CDMO Market Revenues & Volume, By CRO, 2021- 2031F |
6.3.4 Colombia Large Molecule Drug Substance CDMO Market Revenues & Volume, By Others, 2021- 2031F |
7 Colombia Large Molecule Drug Substance CDMO Market Import-Export Trade Statistics |
7.1 Colombia Large Molecule Drug Substance CDMO Market Export to Major Countries |
7.2 Colombia Large Molecule Drug Substance CDMO Market Imports from Major Countries |
8 Colombia Large Molecule Drug Substance CDMO Market Key Performance Indicators |
8.1 Percentage of biologics in the pharmaceutical market in Colombia |
8.2 Number of partnerships between local pharmaceutical companies and international CDMOs |
8.3 Investment in research and development for large molecule drug substance production in Colombia |
8.4 Number of skilled professionals trained in large molecule drug substance manufacturing technologies in the country |
9 Colombia Large Molecule Drug Substance CDMO Market - Opportunity Assessment |
9.1 Colombia Large Molecule Drug Substance CDMO Market Opportunity Assessment, By Service, 2021 & 2031F |
9.2 Colombia Large Molecule Drug Substance CDMO Market Opportunity Assessment, By Source, 2021 & 2031F |
9.3 Colombia Large Molecule Drug Substance CDMO Market Opportunity Assessment, By End-user, 2021 & 2031F |
10 Colombia Large Molecule Drug Substance CDMO Market - Competitive Landscape |
10.1 Colombia Large Molecule Drug Substance CDMO Market Revenue Share, By Companies, 2024 |
10.2 Colombia Large Molecule Drug Substance CDMO Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |